Company news

Inoviq Ltd news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Successful completion of Share Purchase Plan

July 4, 2024

INOVIQ lodges SPP and Options Prospectus

June 18, 2024

INOVIQ isolates brain-derived exosomes in Alzheimer's

June 12, 2024

INOVIQ completes $7m placement

June 12, 2024

Breakthrough Exosome Therapy

June 2, 2024

Quarterly Activities Report and Appendix 4C - March 2024

April 30, 2024

Ovarian Cancer Test Validation

April 18, 2024

INOVIQ Investor Update

April 17, 2024

INOVIQ and Promega sign Global EXO-NET Agreement

April 15, 2024

Appendix 4D and FY24 Half Year Financial Report

February 22, 2024

INOVIQ detects 19% more breast cancers than leading test

February 22, 2024

Appendix 4C and Quarterly Activities Report - December 2023

January 30, 2024

2023 AGM CEO Presentation

November 28, 2023

Bell Potter Healthcare Conference Investor Presentation

November 15, 2023

ANSEV Meeting Presentations

November 7, 2023

Appendix 4C and Quarterly Activities Report - September 2023

October 29, 2023

ASX Small and Mid-Cap Conference Investor Presentation

September 19, 2023

IIQ and ResearchDx sign USA EXO-NET Services Agreement

September 4, 2023

Exo-oc program completes serum equivalence study

August 8, 2023

INOVIQ Investor Briefing

July 31, 2023

Appendix 4C and Quarterly Activities Report - June 2023

July 27, 2023

INOVIQ and Promega announce Global Joint Marketing Agreement

July 5, 2023

SubB2M/CA15.3 Clinical Validation Data Investor Presentation

June 29, 2023

Excellent Clinical Data for SubB2M/CA15-3 Breast Cancer Test

June 26, 2023

ISEV Meeting Presentations

May 18, 2023

Appendix 4C and Quarterly Activities Report - March 2023

April 27, 2023

Appendix 4D and Half Year Financial Report

February 23, 2023

Positive results for SubB2M Breast Cancer Test

February 7, 2023

Appendix 4C & Quarterly Activities Report - December 2022

January 30, 2023

Positive EXO-NET Results in Ovarian Cancer

December 12, 2022

MST Access Diagnostics Forum Presentation

December 4, 2022

CEO AGM Presentation

November 27, 2022

INOVIQ Settles Legal Proceedings

November 27, 2022

Commercial and R&D Update

November 24, 2022

Healthcare Conference Investor Presentation

November 10, 2022

IIQ Appendix 4C & Quarterly Activities Report-September 2022

October 27, 2022

Canadian Patent Granted for BARD1 Technology

October 27, 2022

Receipt of R&D Tax Incentive Refund

October 13, 2022

INOVIQ to Develop SubB2M-Based Test on Nicoya SPR Platform

October 12, 2022

2022 Annual Report and update on results

September 27, 2022

IIQ Investor Presentation

August 9, 2022

IIQ Appendix 4C & Quarterly Activities Report - June 2022

July 26, 2022

Positive SubB2M IHC Results for Melanoma

July 26, 2022

hTERT US Patent Granted

July 21, 2022

INOVIQ Engages Sales Team to Accelerate EXO-NET Roll-out

July 20, 2022

SubB2M US Patent Grant and Program Update

July 1, 2022

Australian Patent Granted for SubB2M Technology

May 2, 2022

INOVIQ Key Manufacturing Agreement to Advance SubB2M tests

May 1, 2022

IIQ Appendix 4C & Quarterly Activities Report - March 2022

April 29, 2022

INOVIQ Engages ResearchDX to Develop & Validate SubB2M-Tests

April 4, 2022

← Newer news releases · Older news releases →

Decks

The 5 newest of 31 decks. Every deck is listed under its year.